MANCHESTER, England--(BUSINESS WIRE)--Synexus has recently formed two therapeutic advisory boards in respiratory and cardiac medicine. Professor John Kastelein, who is Professor of Medicine at the Department of Vascular Medicine at the Academic Medical Center (AMC) of the University of Amsterdam, where he holds the Strategic Chair of Genetics of Cardiovascular Disease is chair of the cardiac board. Professor Clive Page, who is the Director of the Sackler Institute of Pulmonary Pharmacology and Joint Head of the Institute of Pharmaceutical Science at King’s College London, is chair of the respiratory board.
